Morgan Stanley Cumulative Gross Losses and Impairments decreased by 91.1% to $700.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $700.00M to $700.00M. Over 4 years (FY 2021 to FY 2025), Cumulative Gross Losses and Impairments shows a downward trend with a -15.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A rising trend indicates persistent underperformance or market-wide stress affecting the firm's long-term holdings.
This metric aggregates all unrealized losses and impairment charges on investments that have not yet been recognized in...
Reported in equity or comprehensive income disclosures for firms with significant investment portfolios.
cumulative_gross_losses_and_impairments| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.37B | $4.79B | $7.74B | $11.24B | $10.63B | $9.60B | $10.26B | $12.38B | $700.00M | $10.14B | $10.24B | $8.05B | $700.00M | $8.88B | $8.70B | $7.91B | $700.00M |
| QoQ Change | — | +250.6% | +61.7% | +45.3% | -5.5% | -9.7% | +7.0% | +20.6% | -94.3% | >999% | +1.0% | -21.4% | -91.3% | >999% | -2.0% | -9.2% | -91.1% |
| YoY Change | — | — | — | — | +678.6% | +100.5% | +32.6% | +10.1% | -93.4% | +5.7% | -0.2% | -35.0% | +0.0% | -12.5% | -15.0% | -1.8% | +0.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.